Cost components | Outpatients | Inpatients at RD | ICU | ||||||
---|---|---|---|---|---|---|---|---|---|
All (N = 210) | RSV positive (n = 21) | RSV negative (n = 189) | p-value** | All (N = 318) | RSV positive (n = 84) | RSV negative (n = 234) | p-value** | All RSV negative*** (n = 8) | |
Total direct medical costs | 22 (13–32) | 26 (16–32) | 21 (13–32) | 0.35 | 84 (50–135) | 68 (47–102) | 91 (59–153) | 0.001 | 1996 (937–3786) |
Medication costs | 15 (9–20) | 15 (8–18) | 15 (9–20) | 0.46 | 9 (4–19) | 10 (4–21) | 9 (5–19) | 0.85 | 114 (20–678) |
 Antibiotics | 3 (2–5) | 2 (1–4) | 3 (2–5) | 0.06 | 2 (1–4) | 1 (1–3) | 2 (1–5) | 0.003 | 82 (2–705) |
 Corticosteroids | 1 (0–1) | 0 (0–0) | 1 (0–1) | 0.16 | 0 (0–0) | 0 (0–1) | 0 (0–0) | 0.33 | 0 (0–17) |
 Bronchodilator oral | 1 (1–1) | 1 (1–1) | 1 (1–1) | 0.16 | 1 (1–1) | 1 (0–1) | 1 (1–1) | 0.95 | 0 (0–0) |
 Bronchodilator inhalation | 1 (1–3) | 2 (1–3) | 1 (1–3) | 0.94 | 5 (2–18) | 11 (2–18) | 4 (2–17) | 0.48 | 7 (2–13) |
 Other drugs | 4 (3–6) | 4 (3–5) | 4 (3–7) | 0.25 | 2 (2–4) | 2 (2–3) | 2 (2–4) | 0.04 | 52 (11–367) |
Laboratory costs | 0 (0–2) | 0 (0–2) | 0 (0–2) | 0.88 | 2 (2–13) | 2 (0–3) | 4 (2–17) | < 0.001 | 193 (64–359) |
Imaging costs | 3 (3–5) | 3 (3–3) | 3 (3–5) | 0.85 | 6 (3–16) | 3 (3–12) | 6 (3–16) | 0.03 | 28 (10–85) |
 Chest X-ray | 3 (3–3) | 3 (3–3) | 3 (3–3) | 0.80 | 3 (3–6) | 3 (3–3) | 3 (3–6) | 0.37 | 6 (4–11) |
 Echocardiogram | 9 (9–9) | 9 (9–9) | 9 (9–9) | N/A | 7 (1–12) | 0 (0–0) | 7 (1–12) | N/A | 3 (3–3) |
 Ultrasound | 2 (2–9) | 2 (2–2) | 2 (2–9) | 0.43 | 13 (2–13) | 2 (2–4) | 13 (4–13) | < 0.001 | 8 (3–10) |
Procedure & service costs | 6 (3–11) | 8 (4–13) | 6 (3–11) | 0.14 | 49 (24–71) | 29 (19–58) | 50 (29–88) | < 0.001 | 1,356 (524–2468) |
Consultation costs | 3 (2–4) | 2 (2–3) | 3 (2–4) | 0.20 | 3 (2–6) | 3 (2–6) | 3 (2–5) | 0.67 | 4 (2–6) |
Miscellaneous costs* | 8 (1–13) | 0 (0–0) | 8 (1–3) | N/A | 13 (6–23) | 12 (6–23) | 13 (6–23) | 0.31 | 204 (120–332) |